Endovascular Therapies to Treat Iliofemoral Deep Venous Thrombosis

Progress in Cardiovascular Diseases

Volumn 54, Issue 1, 2011, Pages 70-76

  Jenkins, J Stephen ^a  

^a JOHN OCHSNER HEART AND VASCULAR INSTITUTE   (United States)

Author keywords

Catheter directed thrombolysis; Distal deep venous thrombosis; Iliofemoral deep venous thrombosis; Percutaneous mechanical thrombectomy; Proximal deep venous thrombosis; Venous thromboembolism

Indexed keywords

ALTEPLASE; ARGATROBAN; DALTEPARIN; ENOXAPARIN; FONDAPARINUX; HEPARIN; LEPIRUDIN; STREPTOKINASE; TINZAPARIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CATHETER DIRECTED THROMBOLYSIS; CONTINUOUS INFUSION; DEEP VEIN THROMBOSIS; ENDOVASCULAR SURGERY; FEMORAL ARTERY; FIBRINOLYTIC THERAPY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; ILIAC ARTERY; LUNG EMBOLISM; NON INVASIVE PROCEDURE; PERCUTANEOUS THROMBECTOMY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTTHROMBOSIS SYNDROME; PROGNOSIS; STENT; THROMBUS ASPIRATION;

ANGIOPLASTY, BALLOON; ANTICOAGULANTS; ENDOVASCULAR PROCEDURES; FEMORAL VEIN; HUMANS; ILIAC VEIN; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STENTS; THROMBECTOMY; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 79959762538     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2011.03.008     Document Type: Article

References (67)

1. Lloyd-Jones D., Adams R., Carnethon M., et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119:480-486.
2. Kearon C., Kahn S.R., Agnelli G., et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008, 133:454S-545S.
3. Torbicki A., Perrier A., Konstantinides S., et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008, 29:2276-2315.
4. Kahn S.R., Shrier I., Julian J.A., et al. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med 2008, 149:698-707.
5. Raju S., Fountain T., Neglen P., et al. Axial transformation of the profunda femoris vein. J Vasc Surg 1998, 27:651-659.
6. Raju S., Fredericks R. Venous obstruction: an analysis of one hundred thirty-seven cases with hemodynamic, venographic, and clinical correlations. J Vasc Surg 1991, 14:305-313.
7. Vedantham S., Grassi C.J., Ferral H., et al. Reporting standards for endovascular treatment of lower extremity deep vein thrombosis. J Vasc Interv Radiol 2006, 17:417-434.
8. Akesson H., Brudin L., Dahlstrom J.A., et al. Venous function assessed during a 5 year period after acute ilio-femoral venous thrombosis treated with anticoagulation. Eur J Vasc Surg 1990, 4:43-48.
9. Delis K.T., Bountouroglou D., Mansfield A.O. Venous claudication in iliofemoral thrombosis: long-term effects on venous hemodynamics, clinical status, and quality of life. Ann Surg 2004, 239:118-126.
10. O'Donnell T.F., Browse N.L., Burnand K.G., et al. The socioeconomic effects of an iliofemoral venous thrombosis. J Surg Res 1977, 22:483-488.
11. Strandness D.E., Langlois Y., Cramer M., et al. Long-term sequelae of acute venous thrombosis. JAMA 1983, 250:1289-1292.
12. Douketis J.D., Crowther M.A., Foster G.A., et al. Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis?. Am J Med 2001, 110:515-519.
13. Barritt D.W., Jordan S.C. Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet 1960, 1:1309-1312.
14. Breddin H.K., Hach-Wunderle V., Nakov R., et al. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis. N Engl J Med 2001, 344:626-631.
15. Fiessinger J.N., Lopez-Fernandez M., Gatterer E., et al. Once-daily subcutaneous dalteparin, a low molecular weight heparin, for the initial treatment of acute deep vein thrombosis. Thromb Haemost 1996, 76:195-199.
16. Gould M.K., Dembitzer A.D., Doyle R.L., et al. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials. Ann Intern Med 1999, 130:800-809.
17. Hull R.D., Raskob G.E., Pineo G.F., et al. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med 1992, 326:975-982.
18. Lindmarker P., Holmstrom M., Granqvist S., et al. Comparison of once-daily subcutaneous Fragmin with continuous intravenous unfractionated heparin in the treatment of deep vein thrombosis. Thromb Haemost 1994, 72:186-190.
19. Merli G., Spiro T.E., Olsson C.G., et al. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Ann Intern Med 2001, 134:191-202.
20. Brandjes D.P., Heijboer H., Buller H.R., et al. Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis. N Engl J Med 1992, 327:1485-1489.
21. Levine M.N., Raskob G., Landefeld S., et al. Hemorrhagic complications of anticoagulant treatment. Chest 2001, 119:108S-121S.
22. Raschke R.A., Gollihare B., Peirce J.C. The effectiveness of implementing the weight-based heparin nomogram as a practice guideline. Arch Intern Med 1996, 156:1645-1649.
23. Raschke R.A., Reilly B.M., Guidry J.R., et al. The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial. Ann Intern Med 1993, 119:874-881.
24. Buller H.R., Davidson B.L., Decousus H., et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med 2003, 349:1695-1702.
25. Buller H.R., Davidson B.L., Decousus H., et al. Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial. Ann Intern Med 2004, 140:867-873.
26. Kearon C., Ginsberg J.S., Julian J.A., et al. Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism. JAMA 2006, 296:935-942.
27. AbuRahma A.F., Perkins S.E., Wulu J.T., et al. Iliofemoral deep vein thrombosis: conventional therapy versus lysis and percutaneous transluminal angioplasty and stenting. Ann Surg 2001, 233:752-760.
28. Arnesen H., Hoiseth A., Ly B. Streptokinase of heparin in the treatment of deep vein thrombosis. Follow-up results of a prospective study. Acta Med Scand 1982, 211:65-68.
29. Comerota A.J., Throm R.C., Mathias S.D., et al. Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life. J Vasc Surg 2000, 32:130-137.
30. Elsharawy M., Elzayat E. Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis. A randomised clinical trial. Eur J Vasc Endovasc Surg 2002, 24:209-214.
31. Enden T., Klow N.E., Sandvik L., et al. Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency. J Thromb Haemost 2009, 7:1268-1275.
32. Hull R.D., Marder V.J., Mah A.F., et al. Quantitative assessment of thrombus burden predicts the outcome of treatment for venous thrombosis: a systematic review. Am J Med 2005, 118:456-464.
33. Meissner M.H., Manzo R.A., Bergelin R.O., et al. Deep venous insufficiency: the relationship between lysis and subsequent reflux. J Vasc Surg 1993, 18:596-605. [discussion 6-8].
34. Mewissen M.W., Seabrook G.R., Meissner M.H., et al. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology 1999, 211:39-49.
35. O'Shaughnessy A.M., Fitzgerald D.E. The patterns and distribution of residual abnormalities between the individual proximal venous segments after an acute deep vein thrombosis. J Vasc Surg 2001, 33:379-384.
36. Prandoni P., Frulla M., Sartor D., et al. Vein abnormalities and the post-thrombotic syndrome. J Thromb Haemost 2005, 3:401-402.
37. Prandoni P., Lensing A.W., Prins M.H., et al. Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med 2002, 137:955-960.
38. Semba C.P., Dake M.D. Iliofemoral deep venous thrombosis: aggressive therapy with catheter-directed thrombolysis. Radiology 1994, 191:487-494.
39. Turpie A.G., Levine M.N., Hirsh J., et al. Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Results of a randomized trial. Chest 1990, 97:172S-175S.
40. Nielsen T.T., Lund O., Ronne K., et al. Changing electrocardiographic findings in pulmonary embolism in relation to vascular obstruction. Cardiology 1989, 76:274-284.
41. Goldhaber S.Z., Buring J.E., Lipnick R.J., et al. Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. Am J Med 1984, 76:393-397.
42. Goldhaber S.Z., Meyerovitz M.F., Green D., et al. Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis. Am J Med 1990, 88:235-240.
43. Vedantham S., Thorpe P.E., Cardella J.F., et al. Quality improvement guidelines for the treatment of lower extremity deep vein thrombosis with use of endovascular thrombus removal. J Vasc Interv Radiol 2006, 17:435-447. quiz 48.
44. Grunwald M.R., Hofmann L.V. Comparison of urokinase, alteplase, and reteplase for catheter-directed thrombolysis of deep venous thrombosis. J Vasc Interv Radiol 2004, 15:347-352.
45. Shortell C.K., Queiroz R., Johansson M., et al. Safety and efficacy of limited-dose tissue plasminogen activator in acute vascular occlusion. J Vasc Surg 2001, 34:854-859.
46. Sugimoto K., Hofmann L.V., Razavi M.K., et al. The safety, efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions. J Vasc Surg 2003, 37:512-517.
47. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial. Ann Surg 1994, 220:251-266. [discussion 66-8].
48. Ouriel K., Veith F.J., Sasahara A.A. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators. N Engl J Med 1998, 338:1105-1111.
49. Delomez M., Beregi J.P., Willoteaux S., et al. Mechanical thrombectomy in patients with deep venous thrombosis. Cardiovasc Intervent Radiol 2001, 24:42-48.
50. Kasirajan K., Gray B., Ouriel K. Percutaneous AngioJet thrombectomy in the management of extensive deep venous thrombosis. J Vasc Interv Radiol 2001, 12:179-185.
51. Vedantham S., Vesely T.M., Parti N., et al. Lower extremity venous thrombolysis with adjunctive mechanical thrombectomy. J Vasc Interv Radiol 2002, 13:1001-1008.
52. Arko F.R., Davis C.M., Murphy E.H., et al. Aggressive percutaneous mechanical thrombectomy of deep venous thrombosis: early clinical results. Arch Surg 2007, 142:513-518. discussion 8-9.
53. Tsai J., Georgiades C.S., Hong K., et al. Presumed pulmonary embolism following power-pulse spray thrombectomy of upper extremity venous thrombosis. Cardiovasc Intervent Radiol 2006, 29:678-680.
54. Cynamon J., Stein E.G., Dym R.J., et al. A new method for aggressive management of deep vein thrombosis: retrospective study of the power pulse technique. J Vasc Interv Radiol 2006, 17:1043-1049.
55. Hilleman D.E., Razavi M.K. Clinical and economic evaluation of the Trellis-8 infusion catheter for deep vein thrombosis. J Vasc Interv Radiol 2008, 19:377-383.
56. Kim H.S., Patra A., Paxton B.E., et al. Adjunctive percutaneous mechanical thrombectomy for lower-extremity deep vein thrombosis: clinical and economic outcomes. J Vasc Interv Radiol 2006, 17:1099-1104.
57. Lin P.H., Zhou W., Dardik A., et al. Catheter-direct thrombolysis versus pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis. Am J Surg 2006, 192:782-788.
58. O'Sullivan G.J., Lohan D.G., Gough N., et al. Pharmacomechanical thrombectomy of acute deep vein thrombosis with the Trellis-8 isolated thrombolysis catheter. J Vasc Interv Radiol 2007, 18:715-724.
59. Rao A.S., Konig G., Leers S.A., et al. Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosis: an alternative in patients with contraindications to thrombolysis. J Vasc Surg 2009, 50:1092-1098.
60. Vedantham S., Vesely T.M., Sicard G.A., et al. Pharmacomechanical thrombolysis and early stent placement for iliofemoral deep vein thrombosis. J Vasc Interv Radiol 2004, 15:565-574.
61. Hartung O., Loundou A.D., Barthelemy P., et al. Endovascular management of chronic disabling ilio-caval obstructive lesions: long-term results. Eur J Vasc Endovasc Surg 2009, 38:118-124.
62. Neglen P., Tackett T.P., Raju S. Venous stenting across the inguinal ligament. J Vasc Surg 2008, 48:1255-1261.
63. Cockett F.B., Thomas M.L. The iliac compression syndrome. Br J Surg 1965, 52:816-821.
64. Lou W.S., Gu J.P., He X., et al. Endovascular treatment for iliac vein compression syndrome: a comparison between the presence and absence of secondary thrombosis. Korean J Radiol 2009, 10:135-143.
65. Mickley V., Schwagierek R., Rilinger N., et al. Left iliac venous thrombosis caused by venous spur: treatment with thrombectomy and stent implantation. J Vasc Surg 1998, 28:492-497.
66. Hartung O., Benmiloud F., Barthelemy P., et al. Late results of surgical venous thrombectomy with iliocaval stenting. J Vasc Surg 2008, 47:381-387.
67. Raju S., Neglen P. Percutaneous recanalization of total occlusions of the iliac vein. J Vasc Surg 2009, 50:360-368.